Telomir Pharmaceuticals OverviewTelomir Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TELO.
Quarterly EBIT
-$1.04M
As of Mar 31, 2026
Annual EBIT (TTM)
-$9.34M
↑ 35.24% YoY
Trailing 12 months ending Mar 31, 2026
Telomir Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for TELO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026